Market InstituteMarket Institute
  • About
    • Who We Are
  • Research & Commentary
    • Papers
  • Events
  • Issues
  • Projects
    • International Overreach: When Global Standards Become U.S. Policy
    • Alzheimer’s
    • Letters
    • Political Cartoons

Research & Commentary

Articles

American Housing Dream, American Housing Nightmare

A new column by The Market Institute President Charles Sauer Read more…

By admin, 8 months8 months ago
Letter

Market Institute and Center for a Free Economy Lead Coalition Letter Supporting the “More Homes on the Market Act”

The Market Institute and the Center for a Free Economy Read more…

By admin, 8 months8 months ago
Articles

Sorry FTC, the First Amendment Trumps Antitrust Law

The intersection of antitrust enforcement and free speech is once Read more…

By admin, 8 months8 months ago
Articles

Meet the New FTC Boss, Same As the Old FTC Boss

In a recent column for RealClearMarkets, Charles Sauer, President of Read more…

By admin, 8 months8 months ago
Alzheimer's

American Healthcare Reacts to Crises, Rather Than Prevent Them

Healthcare is intensely personal, especially when devastating diagnoses arrive. Yet Read more…

By admin, 8 months8 months ago
Letter

Market Institute Joins Coalition Opposing Most-Favored-Nation Drug Pricing

The Market Institute joined dozens of free-market, taxpayer, and innovation-focused Read more…

By admin, 9 months9 months ago
Articles

Without Reform, Healthcare Will Swallow the Federal Budget

In a recent column for RealClearMarkets, Market Institute Senior Fellow Read more…

By admin, 9 months9 months ago
Articles

TrumpRx Is a Prescription for Failure

In a recent article for RealClearHealth, Market Institute President Charles Read more…

By admin, 9 months9 months ago
Articles

They Can Keep Greenland. Let Us Have Free Speech

In a new RealClearMarkets op-ed, Market Institute Senior Fellow Norm Read more…

By admin, 9 months9 months ago
Events

What Both Parties Are Missing on Health Reform

As Congress revisits health reform, much of the debate still Read more…

By admin, 9 months9 months ago

Posts pagination

Previous 1 … 6 7 8 … 39 Next
Recent Articles
  • A Government That’s Trying to Please You Will Make You Miserable October 16, 2026
  • How I Stopped Worrying, and Learned to Love Data Centers October 15, 2026
  • Charles Sauer: Government Policy Is Fueling Hospital Consolidation October 13, 2026
  • Patients First Act: Protecting Choice and Taxpayers October 9, 2026
  • Most Favored Nation Price Controls Disfavor Patients October 5, 2026
Recent Papers
  • The Trouble with Tariffs
  • The $135 Billion Lie: How Upcoding Is Draining Medicare and Medicaid
  • Why Does the Government Pay More for the Same Care?
  • The Practical, Constitutional, and Moral Case Against Social Media Regulation “For the Children”
  • Free Markets Under Attack from the Left and Right

Loading

By adding your phone number, you opt in to receive text messages

Facebook
Twitter
YouTube

The Market Institute Verified account Follow

We promote free market public policies. We get government out of the way.

MarketInstitute
marketinstitute

The Market Institute

Verified account @marketinstitute ·
23 Oct

Businesses should be able to succeed or fail based on how they perform, not how much the government has invested in them. A free market means letting businesses compete on their own, not having the government take a bigger seat at the table.

Stephen Moore @StephenMoore

Memo to the Trump administration: Stop buying companies.

A government $40 trillion in debt should be SELLING assets, not buying ownership stakes in 36 companies.

We thought government control of the means of production was what we were fighting against.

Reply on Twitter 2113667268819182035 Retweet on Twitter 2113667268819182035 Like on Twitter 2113667268819182035 X 2113667268819182035
marketinstitute

The Market Institute

Verified account @marketinstitute ·
23 Oct

The goal should be simple: protect national security without blocking promising medicines from reaching American patients.

Broad biotech restrictions risk doing exactly that.

Axios @axios

Trump administration proposes new curbs on China biotech deals https://www.axios.com/2026/10/23/trump-china-biotech-restrictions?utm_campaign=mrf-utm_source=x&utm_medium=organic_social&utm_campaign=editorial&utm_source=twitter&utm_medium=social&mrfcid=202610236ad04fc1adeaa64e72130b68

Reply on Twitter 2113627990798049521 Retweet on Twitter 2113627990798049521 Like on Twitter 2113627990798049521 X 2113627990798049521
marketinstitute

The Market Institute

Verified account @marketinstitute ·
23 Oct

Protecting inventors is a founding American principle. Strong patent rights give innovators the incentive to build what comes next.

As @newtgingrich puts it:

“We want to encourage inventors. We want to give them legal protection so they have an incentive.”

Reply on Twitter 2113626326032928990 Retweet on Twitter 2113626326032928990 Like on Twitter 2113626326032928990 X 2113626326032928990

  • About
  • Research & Commentary
  • Events
  • Issues
  • Projects